Detalhe da pesquisa
1.
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.
Endocr Pract
; 29(5): 305-340, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150579
2.
Gap in Willingness and Access to Video Visit Use Among Older High-risk Veterans: Cross-sectional Study.
J Med Internet Res
; 24(4): e32570, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394440
3.
Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine.
Curr Diab Rep
; 18(10): 95, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187176
4.
Metformin and ageing: improving ageing outcomes beyond glycaemic control.
Diabetologia
; 60(9): 1630-1638, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770328
5.
Reducing Disparities in Cholesterol Control.
JAMA
; 328(8): 714-716, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997750
6.
Weight loss and physical activity for disease prevention in obese older adults: an important role for lifestyle management.
Curr Diab Rep
; 14(10): 539, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25183491
7.
GAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study.
J Endocr Soc
; 8(3): bvad179, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38333889
8.
BMI, insulin sensitivity, and cognition in early type 2 diabetes: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study.
Obesity (Silver Spring)
; 31(7): 1812-1824, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368512
9.
Recognizing the Needs of High-Need High-Risk Veterans.
Clin Interv Aging
; 17: 1907-1918, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601358
10.
Islet Autoimmunity is Highly Prevalent and Associated With Diminished ß-Cell Function in Patients With Type 2 Diabetes in the Grade Study.
Diabetes
; 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061024
11.
How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
BMJ
; 356: i6505, 2017 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096078
12.
A new angle for glp-1 receptor agonist: the medical economics argument. Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1-13 [Epub ahead of print].
J Med Econ
; 18(12): 1029-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337323